Approval · Notice of Compliance 2501 · 2001
PEG-INTRON: Notice of Compliance 2501
Issued December 17, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2501
- Date
- December 17, 2001
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing procedure
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEG-INTRON | Not yet assigned | — |
Medicinal ingredients
- PEGINTERFERON ALFA-2B 74 MCG per VIAL
- PEGINTERFERON ALFA-2B 118.4 MCG per VIAL
- PEGINTERFERON ALFA-2B 177.6 MCG per VIAL
- PEGINTERFERON ALFA-2B 222 MCG per VIAL